← Back to Feed
Mastek
Q4FY26 Software Services April 20, 2026
Management Sentiment
6.0/10
Tailwinds
6.0/10
Headwinds
7.0/10
Business Performance Highlights
Executive Summary

Mastek delivered a stable Q4 FY26 with 3.6% QoQ revenue growth and maintained 16.1% EBITDA despite macro headwinds and pricing pressures. The company completed fundamental resets across geographies, particularly in North America, with 12-month order backlog growing 13.5% YoY in USD (24.4% in INR), providing a stronger foundation entering FY27. However, management maintained cautious optimism given AI-driven pricing competition, volatile macro environment, and ongoing transition from time-and-materials to outcome-based business models.

Financial Performance

Mastek reported Q4 FY26 revenue of $103.5M (up 1.4% QoQ) and INR 938 crores (up 3.6% QoQ). For the full year FY26, revenue was $421.2M (up 3.1% YoY) and INR 3,699 crores (up 7% YoY). Q4 EBITDA margin was 16.1%, impacted by 1.1% salary increase headwind but supported by 0.8% forex tailwind. Full year EBITDA margin was 15.8%, flat YoY despite pricing pressures. Q4 PAT was INR 106 crores (11% margin), down 0.7% sequentially due to labor code true-up impact. Full year PAT was INR 404 crores (10.7% of total income), up 7.5% YoY. Basic EPS for FY26 was 130.45 (up 7.1% YoY). The company took an exceptional charge of INR 23.7 crores in Q4 (INR 16 crore gratuity, INR 7.7 crore leave encashment) plus INR 6.4 crores in Q3 related to labor code changes, totaling INR 30 crores impact for the year. Utilization improved to 80% in Q4, up 3.3% from Q3. Headcount was 4,730, with net addition of 54 in Q4.

Revenue
Q4: $103.5M, INR 938 crores | FY26: $421.2M, INR 3,699 crores
Revenue Growth
Q4: 1.4% QoQ (USD), 3.6% QoQ (INR), 0.3% constant currency | FY26: 3.1% YoY (USD), 7% YoY (INR)
Net Profit
Q4: INR 106 crores (11% margin) | FY26: INR 404 crores
Profit Growth
FY26: 7.5% YoY
EBITDA Margin
Q4: 16.1% | FY26: 15.8%
Management Commentary

Management displayed cautiously optimistic sentiment, emphasizing FY26 as a year of 'fundamental resets' across North America leadership/teams, APAC client focus, and UK investments. CEO Umang Nahata repeatedly stressed the positive order backlog momentum as providing a 'stronger foundation' for FY27, with sequential improvements in North America order book for two consecutive quarters. However, he consistently tempered expectations by citing 'severe pricing competitiveness,' 'unstable macro environment,' and 'AI-led pricing pressure.' Management emphasized strategic pivot from 'AI for tech' (efficiency) to 'AI for business' (outcomes), with focus on verticalization and domain expertise. The tone suggested confidence in execution capability but realism about market uncertainties, deliberately avoiding specific growth guidance while indicating FY27 'will be a better performance than previous year.' Management highlighted contract renewals seeing 10-15% discounts (potentially higher), and emphasized shift from time-and-materials to outcome-based fixed-price models as critical strategic transition.

Risks & Challenges Discussed

Mastek faces multiple significant headwinds: (1) Severe pricing pressure from AI-driven efficiency improvements, with contract renewals experiencing 10-15% or higher discounts; (2) Healthcare vertical saw QoQ decline due to timing gaps between project completions and new starts, affecting both UK and North America; (3) Middle East/APAC business facing geopolitical headwinds impacting decision-making on new orders and discretionary spend; (4) North America business required complete reset and remains flat in Q4, still in turnaround phase despite positive order book indicators; (5) Retail and manufacturing showed 2% timing dip; (6) Labor code changes resulted in exceptional charge of INR 30 crores for the year; (7) Transition from time-and-materials to outcome-based models creating revenue recognition uncertainties; (8) Project-based business model in North America (55% fixed-price) creates volatility as projects complete and ramp down; (9) Ongoing macro and geopolitical uncertainties affecting client spending patterns; (10) Competitive intensity increasing in UK public sector and overall market; (11) Active client count declining due to tail account rationalization, potentially indicating churn challenges.

Forward Guidance

Revenue Outlook: Management expects FY27 to show 'positive growth' and 'better performance than FY26' but declined to provide specific numeric guidance. Emphasized 'cautiously positive' outlook given market volatility.

Margin Outlook: Expects to maintain stable EBITDA margin at ~16.1% for FY27, balancing operational efficiency gains and AI improvements against pricing pressures and new AI capability investments

Key Targets:

Key Takeaways from the Call
What Went Well
  • 12-month order backlog grew 13.5% YoY (USD) and 24.4% (INR), strongest in recent periods, providing revenue visibility
  • North America order book grew sequentially for second consecutive quarter (Q3 and Q4) with 'enough lead indicators' for continued growth
  • Financial services vertical showing strong recovery after winning large deals with major institutions in UK and North America
  • Cash position extremely strong at INR 938 crores (up 51% YoY) with operating cash flow up 35%, enabling M&A optionality
  • Revenue per resource improved 12% in FY26 through AI efficiency, demonstrating ability to offset pricing pressure
  • 27+ new AI-focused programs added in Q4, with pipeline shifting from discovery to implementation phase
  • DSO at 73 days (12-quarter low) indicates strong collections and working capital management
  • UK healthcare business grew 24% (USD), 90%+ (INR) with NHS relationship expanding into data and AI innovations
Areas of Concern
  • Revenue growth of only 3.1% YoY (USD) significantly underperformed despite 13.5% order backlog growth, indicating conversion challenges
  • Healthcare vertical declined QoQ in both UK and North America due to project timing gaps, despite being labeled core focus area
  • Contract renewals experiencing 10-15% or higher pricing discounts due to AI-driven efficiency expectations
  • North America business flat in Q4 despite two quarters of order book improvement, turnaround not yet translating to revenue
  • Middle East geopolitical issues impacting new orders and discretionary spending, with uncertainty on duration
  • Labor code exceptional charges of INR 30 crores (INR 23.7 in Q4) unexpectedly impacting profitability
  • Active client count declining through tail rationalization, with revenue concentration risk in top 30-40 clients (65-70% of revenue)
  • Management deliberately cautious on FY27 outlook despite stronger backlog, citing 'volatile macro environment' and 'AI-led changes'
  • Fixed-price business at 40%+ creates project completion risk as seen in North America healthcare ramp-downs
  • EBITDA margin flat YoY at 15.8% despite efficiency improvements, indicating pricing pressure offsetting gains
Analyst Q&A Highlights
Q: When will strong order backlog growth translate to revenue growth in FY27?
A: "Management stated 12-month backlog will execute but book-and-ship faces uncertainties from macro volatility and AI changes. Expect FY27 to grow faster than FY26 but maintained 'cautious' view. North America showing positive lead indicators with sequential order growth continuing."
Q: What is the margin outlook given salary hikes and pricing pressure?
A: "Expect to maintain stable 16.1% EBITDA margin in FY27, balancing operational efficiency and AI improvements against pricing competition and new AI capability investments. Salary hike impact was 1.1% in Q4 but offset by forex (0.8%) and cost efficiencies."
Q: How will AI impact the time-and-materials business model and is the change net positive?
A: "Management believes time-and-materials will shift to outcome-based models. While platform technology is available, significant services needed for workflow modernization, data readiness, adoption, and ROI realization. Lead indicators positive with orders for readiness, business process change, and governance frameworks. Enterprise-scale transformation will create net new revenue opportunities exceeding efficiency losses, but timing uncertain."
Q: What is M&A strategy given strong cash position of INR 938 crores (up 51% YoY)?
A: "M&A thesis shifted from capability/skills acquisition (Oracle, Salesforce, Data) to vertical domain capabilities aligned with verticalization strategy. Focus on assets providing core domain knowledge in Healthcare, BFSI, Manufacturing. Also considering smaller AI investments and partnerships with startups. M&A will be 'more around vertical focus' rather than horizontal tech capabilities."
Q: What are challenges to converting order backlog to revenue growth?
A: "Key challenges: (1) Project-based business model means older projects ramp down as new ones ramp up, creating timing gaps; (2) Macro uncertainties affecting book-and-ship within year; (3) AI-led pricing changes creating commercial model shifts; (4) Healthcare timing gaps between project completions and new starts in both UK and North America; (5) Transitioning from T&M to outcome-based requires new frameworks."
Call Summary

The Q&A session revealed analyst focus on three key concerns: (1) timing of order backlog conversion to revenue growth, (2) sustainability of margins amid AI-driven pricing pressure, and (3) strategic positioning for AI-led business model transformation. Analysts pressed repeatedly on when FY27 growth would materialize given strong backlog, with management consistently responding with 'cautiously positive' language while declining specific guidance. Multiple questions probed the pricing pressure from contract renewals (10-15%+ discounts) and whether AI creates net positive or negative revenue impact long-term. Management emphasized the transition from 'AI for tech' (efficiency) to 'AI for business' (transformation services) as the path forward, arguing that workflow modernization and adoption services will create new revenue streams exceeding efficiency losses, though timing remains uncertain. Questions on geography-specific performance highlighted North America's slow turnaround despite two quarters of order book improvement, and Middle East geopolitical headwinds. Analysts also explored M&A strategy given strong cash position, with management indicating shift toward vertical domain acquisitions rather than horizontal capabilities. The DSO improvement to 73 days and cash generation were positively received. Overall, analysts appeared skeptical about near-term revenue acceleration given flat/modest Q4 performance despite strong backlog, while acknowledging the strategic positioning for AI transformation is sound but execution timeline uncertain.

IMPORTANT:
This is an AI-generated summary of the company's publicly available earnings call transcript, provided for informational and educational purposes only. This is NOT investment advice, stock analysis, or a recommendation to buy, sell, or hold any security. The sentiment scores reflect the tone and content of management's statements during the call and are not predictive of stock performance.

Always conduct your own research and consult with a SEBI-registered investment advisor before making any investment decisions. Past performance is not indicative of future results. The Stock Filter and its affiliates are not responsible for any investment decisions made based on this summary.